Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine

by Shigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, Munehiro Yoshitomi, Takahisa Shirahama, Akira Yamada, Kyogo Itoh, Tetsuro Sasada
Published 2013-01-01

Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer

by Daisuke Muroya, Shigeru Yutani, Shigeki Shichijo, Akira Yamada, Shinjiro Sakamoto, Masayasu Naito, Koji Okuda, Michi Morita, Rin Yamaguchi, Kyogo Itoh
Published 2016-01-01

Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advan...

by Shigeru Yutani, Kazuomi Ueshima, Kazumichi Abe, Atsushi Ishiguro, Junichi Eguchi, Satoko Matsueda, Nobukazu Komatsu, Shigeki Shichijo, Akira Yamada, Kyogo Itoh, Tetsuro Sasada, Masatoshi Kudo, Masanori Noguchi
Published 2015-01-01